Chigusa Morizane

21PUBLICATIONS

126CO-AUTHORS

Social epidemiologyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological methodsMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (21)

Sort by Publication Date:

|May 31, 2026

Distinct epidemiology and treatment outcomes between skeletal and extraskeletal Ewing sarcoma in Japan: a population-based study.

|May 18, 2026

Comprehensive Genomic and Transcriptomic Characterization of MTAP Loss Across Advanced Solid Tumors.

|Jan 21, 2026

HER2 Protein Overexpression, mRNA Expression, and DNA Amplification Across Solid Tumors: Comparison of Next-Generation Sequencing-Based Assays With Immunohistochemistry.

Michiko Nagamine, Takao Fujisawa, Naoya Sakamoto

|Oct 19, 2025

Efficacy and safety of FOLFOX for Japanese patients with advanced biliary tract cancer as second-line or later chemotherapy (JON2107-B study).

Takeshi Terashima, Chigusa Morizane, Akihiko Chida

|Aug 12, 2025

Tasurgratinib (E7090) for cholangiocarcinoma with fibroblast growth factor receptor 2 fusions/rearrangements: a multicenter, open-label, Phase 2 study.

Lin Shen, Huaxin Duan, Takamichi Kuwahara

|Jul 17, 2025

Epidemiologic Features and Age-Related Differences in Management among Patients with Gastrointestinal Stromal Tumors in Japan: A National Cancer Registry Study.

Hidekazu Hirano, Yoichi Naito, Toshirou Nishida

Pageof 4

Frequent Collaborators

Makoto Ueno

Naohiro Okano

Masafumi Ikeda

Takayuki Yoshino

Yoshiaki Nakamura

Yoshito Komatsu

Takao Fujisawa

Shigenori Kadowaki

Hideaki Bando

Eiji Oki

Frequent Collaborators

Makoto Ueno

Naohiro Okano

Masafumi Ikeda

Takayuki Yoshino